Abbott (ticker: ABT, exchange: New York Stock Exchange (.N))
News Release -
Abbott to Present at Merrill Lynch Healthcare Conference
ABBOTT PARK, Ill., Sept. 13 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT)
will present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech
Conference in London on Thursday, Sept. 21. Thomas C. Freyman, executive vice
president, finance and chief financial officer, will make a formal
presentation on the company at 3 a.m. U.S. Central time (9 a.m. London time).
A live audio webcast of the presentation will be accessible through
Abbott's Investor Relations Web site at http://www.abbottinvestor.com . An
archived edition of the presentation will be available later that day.
Abbott is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals and
medical products, including nutritionals, devices and diagnostics. The company
employs 65,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the
company's Web site at http://www.abbott.com .
/CONTACT: Media, Jonathon Hamilton, +1-847-935-8646, or Financial
Community, Larry Peepo, +1-847-935-6722, both of Abbott/
/Company News On-Call: http://www.prnewswire.com/comp/110328.html /
/Web site: http://www.abbott.com
CO: Abbott; Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
ST: Illinois, England
IN: HEA MTC BIO
SU: TDS CCA
-- CGW066 --
1926 09/13/2006 14:56 EDT http://www.prnewswire.com